MicroRNAs as biomarkers of multimodal treatment for rectal cancer

Br J Surg. 2021 Aug 19;108(8):e260-e261. doi: 10.1093/bjs/znab111.

Authors

R M Waldron¹, B M Moloney¹, K Gilligan¹, A J Lowery¹, M R Joyce¹, E Holian², M J Kerin¹, N Miller¹

Affiliations

¹ Discipline of Surgery, Lambe Institute for Translational Research, National University of Ireland, Galway, Ireland.
² School of Mathematics, Statistics and Applied Mathematics, National University of Ireland, Galway, Ireland.

PMID: 33880499
DOI: 10.1093/bjs/znab111

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers, Tumor / biosynthesis
Biomarkers, Tumor / genetics
Combined Modality Therapy
Gene Expression Regulation, Neoplastic*
Humans
MicroRNAs / biosynthesis
MicroRNAs / genetics*
Rectal Neoplasms / genetics
Rectal Neoplasms / metabolism
Rectal Neoplasms / therapy*

Substances

Biomarkers, Tumor
MicroRNAs